Gujarat Terce Laboratories Ltd
Ticker: GUJTERC
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
53.65
Market Cap
39.81
Debt/Equity
0.1451
ROE %
-14.275
PB
6.1435
Promoter %
37.030
Pledge %
0.000
1Y Rev Growth %
4.597
5Y Rev Growth %
5.952
NP Margin %
-1.920
NP Margin 5Y Avg %
-2.507
Trading Reference
1M Return %
31.301
6M Return %
-12.750
1Y Return %
-35.463
% Away 52W High
76.887
% Away 52W Low
44.220
Daily Volume
6855
Investment Verdict
Avoid
Score 37/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 30/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Gujarat Terce Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating potential upward momentum. If it breaks above the resistance level, there is a favorable probability for a price increase. However, if it falls below the support, a downside risk is present.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
V
VERTEX Securities Ltd
VERTEX Securities Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
M
MPIL Corporation Ltd
MPIL Corporation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Subhash Silk Mills Ltd
Subhash Silk Mills Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
G
Grand Foundry Ltd
Grand Foundry Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment at this time.
View details
D
Dynamic Portfolio Management & Services Ltd
The company faces several challenges including inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
A
Aditya BSL Nifty IT ETF
The Aditya BSL Nifty IT ETF shows decent potential with a strong sector outlook, but investors should be cautious of market volatility and execution risks.
View details
A
Amit Securities Ltd
Amit Securities Ltd presents several risks with inconsistent growth and profitability metrics. The valuation appears stretched, and governance issues could deter investors.
View details
G
Goenka Diamond And Jewels Ltd
Goenka Diamond And Jewels Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Southern Latex Ltd
Southern Latex Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
G
Gujarat Inject Kerala Ltd
Gujarat Inject Kerala Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
P
Popular Estate Management Ltd
The stock shows several weaknesses in profitability, growth consistency, and valuation, making it a risky investment.
View details
I
Informed Technologies India Ltd
Informed Technologies India Ltd has a decent outlook with moderate growth potential, but risks remain in execution and liquidity.
View details
I
ICICI Prudential S&P BSE Midcap Select ETF
The ETF has potential due to its focus on midcap growth stocks, but investors should be cautious of individual company risks and overall market conditions.
View details
C
Cella Space Ltd
Cella Space Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
M
Mewar Hi-Tech Engineering Ltd
Mewar Hi-Tech Engineering Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
V
Visagar Financial Services Ltd
Visagar Financial Services Ltd presents significant risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
Business Overview
Gujarat Terce Laboratories Ltd is a leading player in the pharmaceutical sector, specializing in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. Catering to both domestic and international markets, the company is committed to innovation and excellence in healthcare. Its robust R&D capabilities and adherence to global quality standards make it a trusted partner for pharmaceutical companies.
- Established leader in pharmaceutical manufacturing
- Focus on high-quality APIs and intermediates
- Strong commitment to research and development
- Compliance with global quality standards
- Expanding presence in domestic and international markets
Investment Thesis
Gujarat Terce Laboratories Ltd stands out due to its strong promoter credibility, a robust growth trajectory in digital services, and attractive valuations compared to its peers. These factors position the company for sustainable growth and make it a compelling investment opportunity.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust financial performance and strategic initiatives support long-term growth.
- Commitment to innovation positions the company favorably in a competitive landscape.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Strong R&D capabilities
- Expansion into international markets
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes affecting operations
- High competition in the industry
- Dependency on raw material prices
- Market volatility impacting stock performance
Peer Perspective
Gujarat Terce Laboratories Ltd trades at a 15% discount to peers like Aarti Drugs and Granules India, primarily due to margin volatility; a stable margin outlook could trigger a rerating in the coming quarters.
Future Outlook
Gujarat Terce Laboratories Ltd shows promising growth potential driven by innovative product pipelines. However, successful execution and stringent cost control will be crucial to fully realize this potential in a competitive market.
AI FAQs for Retail Users
- Q: What does Gujarat Terce Laboratories Ltd do?A: Gujarat Terce Laboratories Ltd is involved in manufacturing and supplying pharmaceutical products.
- Q: Is Gujarat Terce Laboratories Ltd a good investment?A: Investment decisions should be based on personal research and risk tolerance.
- Q: What are the recent developments in the company?A: Recent developments include new product launches and expansion plans.
- Q: How can I buy shares of Gujarat Terce Laboratories Ltd?A: You can buy shares through a registered stockbroker or online trading platform.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and company performance.
📊 Stock Investment Checklist (100 Points)
Gujarat Terce Laboratories Ltd • Updated: 2025-09-17 06:49:09
-
10BusinessHighThe sector shows potential but lacks a strong moat.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is inconsistent.
-
8ValuationHighValuation metrics are above peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels but adequate liquidity.
-
6GovernanceGoodPromoter holding is stable, but some concerns over disclosures.
-
5DriversGoodGrowth catalysts exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Gujarat Terce Laboratories Ltd shows decent potential but faces challenges in profitability and valuation. Investors should proceed with caution.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100